The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Marta Moreno-Torres, Ernesto López-Pascual, Erika Moro, Anna Rapisarda, Birgitte Lindeman, Anouk Verhoeven, Thomas Luechtefeld, Eva Serrano-Candelas, Hubert Dirven, Mathieu Vinken, José V. Castell, Ramiro Jover. Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes, Biomedicine & Pharmacotherapy. 2025; 191: 118459118459. https://doi.org/10.1016/j.biopha.2025.118459 |
|
2 |
2025 |
Mariana M Ramírez-Mejía, Rolf Teschke, Nahum Méndez-Sánchez. Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury, World Journal of Hepatology. 2025; 17: https://doi.org/10.4254/wjh.v17.i5.105072 |
|
3 |
2025 |
Umesh Jalihal, Rajesh Nanda, Kuldeep Katariya, Balamurugan Ramanathan, Rajesh Kumawat. The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study, Hepatic Medicine: Evidence and Research. 2025; Volume 17: 61. https://doi.org/10.2147/HMER.S527644 |